|

11C-ER176 Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: [11C] ER176, [11C]ER176

Pipeline

Phase 2: 3

Top Sponsors

  • The Methodist Hospital Research Institute1
  • Patrick Lao1
  • Columbia University1

Indications

  • Alzheimer's Disease3
  • Alzheimer Disease3

New York, New York2 trials

Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease

Columbia University Irving Medical Center

Phase 2
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease

Columbia University Irving Medical Center

Phase 2

Houston, Texas1 trial

Systemic and Central Inflammation in AD

Houston Methodist Research Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.